Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults.

NCT05490108 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2 Infection
COVID-19

Interventions

BIOLOGICAL: ZR202-CoV
BIOLOGICAL: ZR202a-CoV
BIOLOGICAL: Comirnaty®

Sponsor

Shanghai Zerun Biotechnology Co.,Ltd